In 2002 was created Flywheel Ventures, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the Santa Fe.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Broadcasting, Health Care. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ByteLight, Lingotek, SlamData.
The top activity for fund was in 2007. The fund is constantly included in 2-6 investment rounds annually. The higher amount of exits for fund were in 2019. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. Comparing to the other companies, this Flywheel Ventures performs on 15 percentage points less the average number of lead investments.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Flywheel Ventures, startups are often financed by True Ventures, Verge Fund, Fort Washington Capital Partners Group. The meaningful sponsors for the fund in investment in the same round are True Ventures, Access Venture Partners, Verge Fund. In the next rounds fund is usually obtained by True Ventures, Fort Washington Capital Partners Group, Access Venture Partners.
Related Funds
Funds with similar focus
Fund Name | Location |
301 Ventures | College Park, Maryland, United States |
AZURE PLUS | Chiyoda, Japan |
Bear Stearns | Atlanta, Georgia, United States |
Centralway Ventures | Switzerland, Zürich, Zurich |
Chengdu High-tech Zone Venture Angel Fund | Chengdu, China, Sichuan |
China Life Private Equity Investment | Beijing, Beijing, China |
CICC Healthcare Investment Fund | Beijing, Beijing, China |
Digital-Healthcare | England, Leeds, United Kingdom |
Grey | New York, New York, United States |
Haier Homecare | - |
Helios Enterprises | - |
Highlander Venture Fund | - |
Huilun Biological Technology | China, Shanghai |
Linkmore Capital | - |
LSP | - |
Rabo Ventures | Amsterdam, Noord-Holland, The Netherlands |
Roivant Sciences | New York, New York, United States |
Spring Camp | Seoul, Seoul-t'ukpyolsi, South Korea |
Zhejiang Changxing Economic and Technological Development | China, Huzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Laxis | 25 Jul 2022 | San Francisco, California, United States | |||
Submittable | $47M | 06 Jun 2022 | Heart of Missoula, Montana, United States | ||
Genome Medical | $60M | 30 Aug 2021 | South San Francisco, California, United States | ||
Genome Medical | $14M | 01 Jul 2020 | South San Francisco, California, United States | ||
Submittable | $10M | 18 Jul 2019 | Heart of Missoula, Montana, United States | ||
Genome Medical | $12M | 29 May 2017 | South San Francisco, California, United States | ||
SlamData | $6M | 22 Feb 2017 | Boulder, Colorado, United States | ||
Submittable | $1M | 11 Dec 2015 | Heart of Missoula, Montana, United States | ||
SlamData | $3M | 30 Jul 2015 | Boulder, Colorado, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Laxis | 25 Jul 2022 | San Francisco, California, United States | |||
Submittable | $47M | 06 Jun 2022 | Heart of Missoula, Montana, United States | ||
Genome Medical | $60M | 30 Aug 2021 | South San Francisco, California, United States | ||
Genome Medical | $14M | 01 Jul 2020 | South San Francisco, California, United States | ||
Submittable | $10M | 18 Jul 2019 | Heart of Missoula, Montana, United States | ||
Genome Medical | $12M | 29 May 2017 | South San Francisco, California, United States | ||
SlamData | $6M | 22 Feb 2017 | Boulder, Colorado, United States | ||
Submittable | $1M | 11 Dec 2015 | Heart of Missoula, Montana, United States | ||
SlamData | $3M | 30 Jul 2015 | Boulder, Colorado, United States |